Cat. No. |
Product Name |
Information |
PC-60413 |
SF-1126
|
SF-1126 is a pan PI3K/BRD4 inhibitor, RGDS-conjugated LY294002 prodrug that exhibits increased solubility and binds to specific integrins. |
PC-60392 |
SN-32976
PI3K/mTOR inhibitor
|
SN-32976 is a novel, potent and selective class I PI3K and mTOR inhibitor with IC50 of 15.1/461/110/134/194 nM for PI3Kα/PI3Kβ/PI3Kγ/PI3Kδ/mTOR, respectively. |
PC-60391 |
BL-140
p110β inhibitor
|
BL-140 is a potent, specific p110β inhibitor with IC50 of 5.74 nM. |
PC-60372 |
Autophinib
Vps34 inhibitor
|
Autophinib is a novel, potent autophagy inhibitor that inhibits autophagy induced by starvation (IC50=90 nM) or rapamycin (IC50=40 nM) by targeting the lipid kinase VPS34 (IC50=19 nM). |
PC-70200 |
MTX-211
PI3K/EGFR inhibitor
|
MTX-211 is a first-in-class, highly selective, dual inhibitor of PI3K and EGFR kinases with IC50 of <100 nM. |
PC-60176 |
INCB040093
PI3Kδ inhibitor
|
Dezapelisib (INCB040093) is a potent, selective, orally available PI3Kδ inhibitor with IC50 of 31 nM. |
PC-60166 |
GDC-0326
PI3Kα inhibitor
|
GDC0326 (GDC-0326) is a potent, selective, orally available PI3Kα inhibitor with Ki of 0.2 nM. |
PC-70090 |
GSK-2292767
PI3Kδ inhibitor
|
GSK-2292767 is a highly potent and selective inhibitor of PI3Kδ (pKi=10.1). |
PC-60057 |
Gedatolisib
PI3K/mTOR inhibitor
|
Gedatolisib (PF-05212384, PKI-587) is a highly potent, selective, dual PI3K/mTOR inhibitor with IC50 of 0.4/6/8/6/1.6 nM for PI3Kα/β/γ/δ/mTOR, respectively. |
PC-45643 |
GSK-2269557
PI3Kδ inhibitor
|
Nemiralisib (GSK-2269557) is a highly potent and selective inhibitor of PI3Kδ (pKi=9.9). |
PC-45597 |
3-Methyladenine
PI3K inhibitor
|
3-Methyladenine (3-MA) is a selective PI3K inhibitor for Vps34 and PI3Kγ with IC50 of 25 uM and 60 uM in HeLa cells. |
PC-45820 |
GDC-0941
PI3K inhibitor
|
Pictilisib (GSC-0941) is a potent, selective, orally bioavailable inhibitor of class I PI3Ks with IC50 of 3/33/3/75 nM for p110α/β/γ/δ, respectively. |